MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 276 filers reported holding MYRIAD GENETICS INC in Q4 2014. The put-call ratio across all filers is 2.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $260,000 | -13.9% | 7,625 | -0.2% | 0.05% | -13.8% |
Q3 2014 | $302,000 | +1.7% | 7,640 | +0.2% | 0.06% | +1.8% |
Q2 2014 | $297,000 | -27.2% | 7,625 | -36.1% | 0.06% | -29.6% |
Q1 2014 | $408,000 | +64.5% | 11,925 | +0.8% | 0.08% | +65.3% |
Q4 2013 | $248,000 | – | 11,825 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
RK Capital | 384,900 | $16,612,000 | 2.90% |
Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |